Lv7
5020 积分 2024-02-23 加入
Abstract PS7-02: First-in-human results of STX-478, a mutant-selective PI3K alpha inhibitor, in HR+ breast cancer and advanced solid tumor patients
9天前
已关闭
Prediction of potential drug-resistant ALK mutations against fourth-generation inhibitors NVL-655 and TPX-0131
5个月前
已完结
Safety, Tolerability, Pharmacokinetics, and Target Engagement of Single and Multiple Ascending Doses of Intravenous AZD4144, a Small Molecule NLRP3 Inhibitor for Treatment of AKI
7个月前
已关闭
Safety, Tolerability, Pharmacokinetics, and Target Engagement of Single and Multiple Ascending Doses of Intravenous AZD4144, a Small Molecule NLRP3 Inhibitor for Treatment of AKI
7个月前
已关闭
Energy Metabolism and Thyroid Function of Mice with Deleted Wolframin (Wfs1) Gene
9个月前
已完结
皖公网安备34019202002308
